EUVIMEDOpdag EUVIMED
Beobachtungsstudie

Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy

Muzaffer Serdar Deniz iD, Merve Dindar iD

Diagnostic Cytopathology · 2024

DOI: 10.1002/dc.25239 ↗

At a glance

Beobachtungsstudie in Diagnostic Cytopathology, 2024. Written by Muzaffer Serdar Deniz and 1 co-authors. Institution: Department of Endocrinology, Faculty of Medicine, Education and Research Hospital, Karabük University, Karabük, Turkey. Major MEDLINE topics: Thyroid Nodule, Thyroid Neoplasms, COVID-19. Cited 4 times so far (Crossref); 34 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

The study explores various factors, including coronavirus disease 2019 (COVID‐19) history and vaccination status, that influence the classification value of ultrasonography‐guided thyroid fine needle aspiration biopsy (TFNAB) by comparing non‐diagnostic (Bethesda‐I) and diagnostic (Bethesda II–VI) results.

Methods

We conducted a retrospective observational study in a high‐volume tertiary care center involving patients who underwent TFNAB from November 2022 to April 2023. The study retrospectively analyzed the cytopathology of 482 thyroid nodules. Patients were categorized into non‐diagnostic ( n = 136) and Diagnostic groups ( n = 346) based on TFNAB. A comprehensive set of parameters was examined, including demographic, anthropometric and clinical data, thyroid ultrasonography findings, COVID‐19 history and immunization status.

Results

The mean age was 55.1 ± 12.1 years in the non‐diagnostic group and 53.5 ± 13 years in the Diagnostic group ( p = .223). 75.7% ( n = 103) of the non‐Diagnostic group and 82.9% ( n = 287) of the Diagnostic group were male ( p = .070). The mean nodule longitudinal diameter of the Diagnostic group was significantly higher than that of the non‐diagnostic group ( p = .015). The TIRADS score of the nodules showed a statistical difference between the groups ( p = .048). The groups had no significant differences regarding other ultrasonographic parameters and COVID‐19‐related variables.

Conclusion

It can be assumed that when the longitudinal diameter of the thyroid nodule is small and in TIRADS categories other than the TIRADS3 category, TFNAB is less likely to be diagnostic. However, future research may be needed to confirm these findings and uncover any long‐term effects of COVID‐19 or vaccines on thyroid nodule diagnostics.

Subjects

MeSH terms (MEDLINE)

Thyroid NoduleThyroid NeoplasmsCOVID-19HumansMaleAdultMiddle AgedAgedFemaleBiopsy, Fine-NeedleRetrospective StudiesUltrasonography

Author keywords

BethesdaCOVID-19nodule diameterthyroid fine needle aspiration biopsythyroid ultrasonography

Authors and institutions

  • Department of Endocrinology, Faculty of Medicine, Education and Research Hospital, Karabük University, Karabük, Turkey.
  • Department of Internal Medicine, Faculty of Medicine, Education and Research Hospital, Karabük University, Karabük, Turkey.

ORCID profiles: Muzaffer Serdar Deniz, Merve Dindar

Cite

APA

Deniz, M. S., & Dindar, M. (2024). Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25239

Vancouver

Deniz MS, Dindar M. Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25239

BibTeX
@article{Deniz2024,
  author = {Deniz, Muzaffer Serdar and Dindar, Merve},
  title = {Examining the impact of several factors including COVID ‐19 on thyroid fine‐needle aspiration biopsy},
  journal = {Diagnostic Cytopathology},
  year = {2024},
  doi = {10.1002/dc.25239}
}
Start for free →